Cambridge, MA, United States of America

Elif Nihal Korkmaz

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Modernatx, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elif Nihal Korkmaz. Retrieved from https://idiyas.com/inventor/elif-nihal-korkmaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elif Nihal Korkmaz and Her Patent Work.

Introduction

Elif Nihal Korkmaz is an inventor associated with Cambridge, Massachusetts, and ModernaTX, Inc. Her work includes a patent concerning mutant influenza B/Victoria lineage virus hemagglutinin proteins.

Latest Patents

Korkmaz is credited with 1 patent: “Mutant Influenza B/Victoria Lineage Virus Hemagglutinin Proteins.” The patent focuses on hemagglutinin proteins from mutant influenza B/Victoria lineage viruses.

Career Highlights

Korkmaz’s listed patent work connects her to ModernaTX, Inc., a biotechnology company. The available information identifies her contribution in the area of influenza virus proteins.

Collaborations

Korkmaz’s listed coworkers include Farbod Mahmoudinobar and Raffael Nachbagauer. Their names are associated with the same patent-related work.

Conclusion

Elif Nihal Korkmaz’s patent record highlights her contribution to research involving mutant influenza B/Victoria lineage virus hemagglutinin proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…